Ads
related to: michael j. fox parkinson's disease
Search results
As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight risks
Fox News· 2 days ago"The thing is, you have it, and you go, ‘I don't feel that great,’ but I don't know what it would be...
Experimental spinal cord implant helps Parkinson’s patient walk in new study
CNN via Yahoo News· 1 day agoMarc Gauthier can now step into an elevator without his body stiffening and freezing in place. He...
IRLAB has Received Approval from the Swedish Medical Products Agency to Conduct a Phase I Study of...
Digital Journal· 5 days agoIRL757 is being developed as a treatment to...
2nd annual Parkinson's Walk
WKBT La Crosse· 6 days agoParkinson's disease is a neurological condition that affects everyone differently. On Saturday, the annual Parkinson
Bronson Rumsey Hall
Chicago Tribune· 6 days agoBronson Rumsey Hall died peacefully on April 27, 2024, at age 83 in Highland Park, Illinois from complications of Parkinson’s disease ...
Quanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoQuanterix Corporation (NASDAQ:QTRX) Q1 2024 Earnings Call Transcript May 8, 2024 Quanterix...
IRLAB Publishes Interim Eeport for the Period January-March 2024
Digital Journal· 3 days agoFigures in brackets = same period 2023, unless otherwise stated.
Marsha Nice
San Jose Mercury News· 6 days agoMarsha “Marti” Nice passed away peacefully with her family by her side on Sunday evening, Oct. 29th, after a long health battle that culminated in a diagnosis of Parkinson ...
Robert 'Bob' Lee Bowman
The Harrisonburg Daily News-Record· 3 days agoRobert "Bob" Lee Bowman, 74, of Richmond, Va., passed away at his home on April 29, 2024, surrounded by his family after a courageous battle with ...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 2 days agoCompany to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated
Ad
related to: michael j. fox parkinson's disease